PFAS in cosmetics: what an ingredient label and FDA's evidence review can—and cannot—show

FDA’s 2025 MoCRA assessment concluded that available data were insufficient for a definitive safety determination about PFAS in cosmetic products. The agency identified intentionally listed PFAS in a subset of formulations, but that does not establish that every cosmetic contains PFAS, that an ingredient list captures trace contamination, or that every detected substance and exposure has the same risk. Read identity, intent, test, exposure, and evidence separately.¹²³

“PFAS” names a very large chemical family. A single yes-or-no badge can hide which chemical, why it was used, whether it was intentionally added, how it was measured, and whether the result relates to real-world use.

Keep four questions separate

Evidence at one layer cannot automatically answer the others. Detecting total fluorine is not the same as identifying a particular PFAS, and finding an ingredient name is not a clinical-outcome study.

What FDA’s assessment actually said

FDA reported that its review did not find enough data to make a definitive safety determination about PFAS in cosmetic products.¹³ “Insufficient data” is not equivalent to proven safe, proven unsafe, banned, or approved. It is an evidence conclusion with important gaps.

The agency also described intentionally added PFAS identified through ingredient information for 1,744 cosmetic formulations as of the reviewed date.¹³ That count is not a prevalence estimate for every product on today’s market, and formulations can be added, discontinued, or changed.

Ingredient lists show intentional formulation, with limits

Cosmetic labels generally list ingredients under federal rules, but an ingredient panel is not designed as a certificate that no trace contaminant is present.⁴ It may help identify intentionally used fluorinated ingredients if you know the exact names, but “PFAS” may not appear as a simple umbrella word.

Preserve the full package, INCI ingredient list, lot, purchase date, country or market version, and manufacturer contact. If a company says “PFAS-free,” ask how it defines PFAS, whether the statement covers intentional ingredients only or analytical testing, which analytes and methods are used, and whether the evidence is batch-specific.

A laboratory result needs method context

Testing can report targeted individual compounds, extractable organic fluorine, total organic fluorine, or another proxy. Each method answers a different question and has its own detection limit, recovery, interference, and sample-preparation issues.

Before repeating a headline, ask:

1. Was the finished product or a raw material tested?
2. Which lot and how many units?
3. Which PFAS analytes were targeted?
4. Was the method validated for that cosmetic matrix?
5. What were detection and quantitation limits?
6. Were blanks, spikes, and replicates reported?
7. Is the result a named compound or a broad fluorine measure?

“Detected” without concentration and method is incomplete. “Not detected” means below that method’s threshold for the tested analytes and sample, not metaphysical absence.

Exposure differs by product and use

An eye-area product, aerosol, long-wear lip product, rinse-off cleanser, hair product, and professional-use formula create different routes and contact patterns. Concentration alone does not establish absorbed dose or outcome. FDA’s assessment reviews these exposure and toxicology limitations rather than treating all cosmetics as one use.³

Avoid personal risk calculations from a social post. Consumers with specific exposure or health concerns should discuss the actual products and use pattern with an appropriate clinician or toxicology resource.

“Clean,” “natural,” and professional do not answer the PFAS question

Marketing categories such as clean beauty, medical grade, vegan, dermatologist tested, mineral, or professional use do not define a PFAS testing standard. The medical-grade-skincare guide explains why channel and branding are not approval categories.

Likewise, replacing one product based only on an ingredient blacklist can introduce different irritants or allergens without solving the question being asked. Compare complete formulations and intended uses.

Audit the PFAS claim at its own level

• Exact product, market version, lot, and current ingredient list
• Named intentionally added fluorinated ingredient, if any
• Company’s definition of “PFAS-free”
• Finished-product testing or supplier declaration
• Laboratory, method, analyte list, and detection limits
• Route, frequency, duration, and amount of use
• Evidence tied to the named compound and relevant exposure
• Date of the claim and reformulation history

Ask the claim to show its evidence chain

Ask: “Is this claim about an intentionally listed PFAS, a named compound detected in this finished-product lot, a broad fluorine screen, or a health effect—and what method and relevant exposure connect those steps?” That question preserves FDA’s uncertainty without erasing useful product information.